NGS 409 gene Mutation Screening (SNV, INDEL) + TMB near me in Ahmedabad

The NGS 409 gene Mutation Screening (SNV, INDEL) + TMB measures this important biomarker, enabling research that explores the correlation between TMB and future therapeutic response in several cancers.Immunotherapy, is a type of treatment given to stimulate or remove inhibition of the immune system can help combat a cancer. Although PD-L1 is used as a biomarker for immunotherapy, but this assay alone remain insufficient as some patients that are negative for PD-L1 expression revealed response to immunotherapy. Since no single biomarker is fully predictive, Tumor mutational burden (TMB), which is the measured as the total number of somatic mutation per Mb of a tumour genome, is a promising emerging biomarker for cancer immunotherapy across many cancer types.Along with TMB Score this panel will give SNV,INDEL for all the 409 genes mentioned.

Note: Genetic counseling can be provided. If interested, please send the request to this email id: [email protected]mailto:[email protected]

Disclaimer: In no event shall the liability of TATA 1MG exceed the amount of actual cost of test charges incurred by the customer as stated on the invoice issued by Tata 1mg.